Oxford Nanopore Technologies (OTCMKTS:ONTTF) Trading Down 12.7% – Here’s What Happened

Oxford Nanopore Technologies plc (OTCMKTS:ONTTF)’s share price traded down 12.7% during mid-day trading on Tuesday . The company traded as low as $2.10 and last traded at $2.14. Approximately 27,445 shares changed hands during mid-day trading, an increase of 16% from the average session volume of 23,603 shares. The stock had previously closed at $2.45.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ONTTF shares. Panmure Gordon raised shares of Oxford Nanopore Technologies to a “buy” rating in a research report on Monday, August 24th. Citigroup restated a “buy” rating on shares of Oxford Nanopore Technologies in a research note on Friday, July 10th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Oxford Nanopore Technologies Price Performance

The company’s 50-day moving average is $1.75 and its two-hundred day moving average is $1.69.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells.